El Hospital Universitario Ramón y Cajal es un complejo hospitalario de titularidad pública situado en el distrito de Fuencarral-El Pardo de Madrid.

During the past decade, Hospital Ramon y Cajal; Servicio de Oncologia conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 31 clinical trials were completed, i.e. on average, 55.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 17 clinical trials were completed. i.e. 89.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Ramon y Cajal; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 58 trials, followed by "Bayer" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Institut de Recherches Internationales Servier" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Ramon y Cajal; Servicio de Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Ramon y Cajal; Servicio de Oncologia" are "Breast Cancer" (9 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Bladder Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials) and "Glioblastoma" (3 trials). Many other conditions were trialed in "Hospital Ramon y Cajal; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Ramon y Cajal; Servicio de Oncologia" are "Drug" (69 trials), "Other" (5 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (29 trials), "Placebo" (16 trials), "Paclitaxel" (12 trials), "Bevacizumab" (11 trials) and "Docetaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Ramon y Cajal; Servicio de Oncologia" are 59 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Ramon y Cajal; Servicio de Oncologia". undefined are not yet recruiting, 10 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Hospital Ramon y Cajal; Servicio de Oncologia, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Ramon y Cajal; Servicio de Oncologia, 9 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".